A. Acid-base imbalance
B. Diarrhoea
D. Nausea
A. All have metabolically active substrates
B. After metabolism of other drugs in liver
C. Produce distortion in sleep more than other sedatives
A. Frank gastric bleeding
B. Prolonged prothrombin time
C. Platelet dysfunction
A. Aspirin
B. Ibuprufen
C. Diclofenac potassium
D. Mefenamic acid
A. Increase APTT
B. Increase PTT
C. Increase CT
B. Pentazonice
C. Nalbuphine
D. Butorphanol
B. Phenylephrine
C. Hyoscin
D. Scoline
A. Tenoxicam
B. Piroxicam
C. Indomethacin
A. Phenobarbita
C. Diazepam
D. Pentobarbital
A. Chronic hepatitis
B. Bleeding disorders
C. Nephritis
A. Phenylbutazone
C. Acetylsalicylic acid
D. Naproxen
A. Bleeding defects
B. peptic ulcer
C. Carcinoma
A. Sufentanil
B. Fentanyl
D. Morphine
A. Aplastic anemia
C. Agranulocytosis
D. Hemolytic anemia
A. It stimulates Prostacyclins
B. It is a vasodilator
D. Ithelps in reducing inflammatory aggregate
A. Nicotinic cholinergic receptors
B. Glutamate receptors
C. Glucocorticoid receptors
A. Aminoglycoside
C. Phenacetin
D. Tetracycline
B. Chloroquine
C. Chlorpheniramine
D. Chlorhexidine
A. Olanzepine
C. Risperidone
D. Clozapine
A. Naltrexone
B. Furazolidone
C. Naloxone
A. They act as neuromodulators
C. They are acidic precursors of Brain amines
D. They are metabolites of various neurogenic amines
A. NSAIDS benefit by preventing prostaglandin synthesis
B. Analgesia is associated with ? and k receptors
D. Dysphoria is associated with S receptors
A. Zopiclone
B. Diazepam
D. Nitrazepam
A. Indomethacin
B. Phenyl butazone
C. Aspirin
A. Beclofen
C. Mephensin
A. Alzhiemers disease
B. Cushings syndrome
C. Vitamin C deficiency
A. Produce analgesia
C. Suppress coughing
D. Produce muscle relaxation
B. Fever
C. Post myocardial infarction
D. Venous thrombosis
B. CNS stimulation
C. CNS depression
D. Decreased salivation
A. Pheno barbital
C. Sodium nitroprusside
D. Glyceryl trinitrite
A. It produces more acetycholine receptors
B. It increases the action of cholinesterase
C. It is produces more acetylcholine
B. Stage I
C. Stage II
D. Stage III plane 2
A. Esophageal spasm
B. Cyanide poisoning
C. CCF
B. Diphenydramine
C. Promethazine
D. Pyrilamine
A. The therapeutic index of the drug
B. Range of disease in which the drug beneficial
C. The therapeutic does range of the drug
A. Sodium citrate
B. Ondansetron
D. Atropine
B. 84%
C. 80.50%
D. 4.75%
A. It causes excertion of Na & Cl
B. It causes metabolic alkalosis
C. It is very potent
A. Prothrombin
B. Acetylsalicylic acid
C. Plasmin
A. Infantile spasm
B. Grand mal epilepsy
D. None of the above
A. A normal healthy individual
C. A patient with mild systemic disease
B. Nutritional component
C. Psychological component
D. Psysiological component
A. Morbidity index
C. Moratality index
D. Anesthetic ratio
A. Flunarizine
B. Propanolol
C. Divalprox sodium
A. Ibuprofen
B. Aspirin
B. phenytoin
C. Corticosteroids
D. Diazepam
B. High K+ levels
C. High Na+ levels
D. High Ca2+ levels
A. Increase in total amount of circulatory neutrophils
C. Anti-inflammatory effect is increased
D. Inhibit phospholipase A2
A. Thiopentone
C. Nitrous oxide
D. Tentanyl
B. Inhibition of thromboxane TXA2
C. Prolonged bleeding time
D. Inhibition of prostaglandin PGI2
Showing 9001 to 9050 of 10266 mcqs